DATA COLLECTION SECTION BY FRONTLINE TEAM. Patient Identifier/ Medical Record number (for facility use only)

Similar documents
Commonwealth of Kentucky Antibiotic Stewardship Practice Assessment For Long-Term Care Facilities

Antimicrobial Stewardship

Jump Start Stewardship

Healthcare-associated Infections and Antimicrobial Use Prevalence Survey

Antimicrobial Stewardship 101

Clinical Practice Standard

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose

UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM

These recommendations were approved for use by the Pharmaceutical and Therapeutics Committee, RCWMCH on 1 February 2017.

8/17/2016 ABOUT US REDUCTION OF CLOSTRIDIUM DIFFICILE THROUGH THE USE OF AN ANTIMICROBIAL STEWARDSHIP PROGRAM

Antibiotic Stewardship in the LTC Setting

Define evidence based practices for selection and duration of antibiotics to treat suspected or confirmed neonatal sepsis

Antimicrobial Stewardship in the Hospital Setting

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources

NEONATAL Point Prevalence Survey. Ward Form

Impact of Antimicrobial Stewardship Program

Using Data to Track Antibiotic Use and Outcomes

Jump Starting Antimicrobial Stewardship

Updates in Antimicrobial Stewardship

Treatment of septic peritonitis

General Surgery Small Group Activity (Facilitator Notes) Curriculum for Antimicrobial Stewardship

Measure Information Form

MHA/OHA HIIN Antibiotic Stewardship/MDRO Collaborative

Standing Orders for the Treatment of Outpatient Peritonitis

Antibiotic stewardship in long term care

Antimicrobial Stewardship

WENDY WILLIAMS, MT(AMT) MSAH DIRECTOR LABORATORY AND PATHOLOGY SERVICES. Appalachian Regional Healthcare System apprhs.org

Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S.

Antibiotic Stewardship in the Neonatal Intensive Care Unit. Objectives. Background 4/20/2017. Natasha Nakra, MD April 28, 2017

Curricular Components for Infectious Diseases EPA

Inappropriate Use of Antibiotics and Clostridium difficile Infection. Jocelyn Srigley, MD, FRCPC November 1, 2012

ANTIBIOTIC STEWARDSHIP. Brian Mayhue, Pharm D, CGP Director of Pharmacy Palm Beach Gardens Medical Center

Best Practices: Goals of Antimicrobial Stewardship

Antibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents

Dr Eleri Davies. Consultant Microbiologist and Infection Control Doctor, Public Health Wales NHS Trust

Antibiotic Stewardship: The Facility Role and Implementation. Tim Cozad, LPN, Lead LTC Health Facilities Surveyor

Objectives. Basic Microbiology. Patient related. Environment related. Organism related 10/12/2017

Clinical Guideline. District Infectious Diseases Management. Go to Guideline. District Infectious Diseases Management CG 18_24

Duke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients

2016/LSIF/FOR/007 Improving Antimicrobial Use and Awareness in Korea

IMPLEMENTATION AND ASSESSMENT OF A GUIDELINE-BASED TREATMENT ALGORITHM FOR COMMUNITY-ACQUIRED PNEUMONIA (CAP)

UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients

Standing Orders for the Treatment of Outpatient Peritonitis

Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16

Assessment of empirical antibiotic therapy in a tertiary-care hospital: An observational descriptive study

The Inpatient Management of Febrile Neutropenia

VCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS

Linda Taggart MD FRCPC Infectious Diseases Physician Lead Physician, Antimicrobial Stewardship Program St. Michael s Hospital

Physician Rating: ( 23 Votes ) Rate This Article:

Antibiotic Stewardship and Critical Access Hospitals. Robert White, BA, PT, CPHQ Program Manager TMF Quality Innovation Network

Appropriate Antimicrobial Use in California: The Path of Least Resistance

Antimicrobial stewardship

Antimicrobial Stewardship Program. Jason G. Newland MD, MEd Miranda Nelson, PharmD

Objectives 4/26/2017. Co-Investigators Sadie Giuliani, PharmD, BCPS Claude Tonnerre, MD Jayme Hartzell, PharmD, MS, BCPS

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form

CURRENT STEWARDSHIP AND EDUCATIONAL ACTIVITY IN RUSSIA FINDINGS FROM A SURVEY

Dr. Charles Onunkwo, Infectious Disease Medicine Erika Ingram, Infectious Disease/Critical Care Clinical Pharmacy Specialist Southeastern Regional

Core Elements of Antibiotic Stewardship for Nursing Homes

Antibiotic Usage Guidelines in Hospital

Antimicrobial Stewardship. October 2012

Antimicrobial Stewardship:

Antimicrobial Stewardship

Antimicrobial Stewardship: Guidelines for its Implementation

UCSF Medical Center Guidelines for Inpatient Management of Febrile Neutropenia

Antibiotic Guideline: Empirical Treatment of Bone and Joint Infection in Adults

ASCENSION TEXAS Antimicrobial Stewardship: Practical Implementation Strategies

Becker s Hospital Review

Antibiotics in the trenches: An ER Doc s Perspective

Antibiotics: Take a Time Out

Host, Syndrome, Bug, Drug: Introducing 2 Frameworks to Approach Infectious Diseases Cases with an Antimicrobial Stewardship Focus

Measurement of Antimicrobial Drug Use. Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS DASON Liaison Pharmacist

MAGNITUDE OF ANTIMICROBIAL USE. Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges

Antimicrobial Stewardship: A Public Health Priority

Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report. July December 2013 Second and Third Quarters 2014

Methicillin-Resistant Staphylococcus aureus Nasal Swabs as a Tool in Antimicrobial Stewardship

Incidence of hospital-acquired Clostridium difficile infection in patients at risk

Bugs, Drugs, and No More Shoulder Shrugs: The Role for Antimicrobial Stewardship in Long-term Care

CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

ANTIMICROBIAL STEWARDSHIP START SMART THEN FOCUS Guidance for Antimicrobial Stewardship for SHSCT

Antibiotic prophylaxis guideline for colorectal, hepatobiliary and vascular surgery for adult patients.

Grey Nuns Community Hospital (GNCH) Antimicrobial Stewardship Report

Understanding the Hospital Antibiogram

Antimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD

Who should read this document 2. Key practice points 2. Background/ Scope/ Definitions 2. What is new in this version 3. Policy/Procedure/Guideline 3

Antimicrobial Stewardship in the Long Term Care and Outpatient Settings. Carlos Reyes Sacin, MD, AAHIVS

Collecting and Interpreting Stewardship Data: Breakout Session

Preventing and Responding to Antibiotic Resistant Infections in New Hampshire

PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS

Antimicrobial Stewardship Basics Why, What, Who, and How

Women s Antimicrobial Guidelines Summary

GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS

The Nuts and Bolts of Antibiograms in Long-Term Care Facilities

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

Rational management of community acquired infections

Antimicrobial utilization: Capital Health Region, Alberta

MEASURING ANTIBIOTIC USE IN LTCFS

Scottish Surveillance of Healthcare Infection Programme (SSHAIP) Health Protection Scotland SSI Surveillance Protocol 7th Edition 2017 Question &

Antimicrobial stewardship in managing septic patients

Antibiotic Stewardship Beyond Hospital Walls

Effectiv. q3) Purpose of Policy. Pharmacy: Antimicrobial subcommp&tittee of

Transcription:

Assessment of Appropriateness of ICU Antibiotics (Patient Level Sheet) **Note this is intended for internal purposes only. Please do not return to PQC.** For this assessment, inappropriate antibiotic use is defined as receiving antibiotics when it is not necessary, not making timely adjustments in the regimen, choosing the wrong regimen due to unsuitable spectrum of activity for the targeted infection, wrong duration, wrong dose, wrong route and wrong interval. This assessment by the frontline provider with support from their ASP is based on national guidelines and/or your facility s guidelines, formulary and local microbiology. This assessment has been tested in multiple hospitals across the US. lease do not send this worksheet or any patient identifying information to PQC. Data from all ICUatients in each ofyour facilities will be aggregated by. Begin by obtaining the census from participating ICUs on [date]. Then determine which patients received antibiotics on this date. Fill out this form for each individual patient receiving antibiotics in the ICU on (date). This is the worksheet for a frontline provider to abstract clinical information and may be filled out by a clinician or pharmacist. Together with a member of the Antibiotic Stewardship Program (ASP), pharmacy or an Infectious Diseases consultant, your team will then assess the appropriateness of the antibiotics and identify possible opportunities for ASP intervention utilizing data available by [date] only. Please obtain the clinical information as close to [date] as possible, as additional information (culture results and laboratory data after [date]) may bias your assessment. DATA COLLECTION SECTION BY FRONTLINE TEAM Patient Identifier/ Medical Record number (for facility use only) 1. Patient Information and Risk Stratification: Date of data collection: Gender: Male Female Age: ICU Type (check all that apply; based on NHSN ICU definitions) Medical ICU Surgical ICU Medical/ Surgical ICU (MSICU) Cardiac/ surgical ICU Tele/ cardiac ICU Neuro ICU Neonatal ICU Pediatric ICU Other ICU please specify Patient Epidemiology (check all that apply) Community resident Long term care resident Hemodialysis Solid organ Transplant recipient Immune suppressive condition (including Diabetes) or therapy

BMT Recent admission w/in 30 days of current admission Current hospitalization at least 5 days Active malignancy 2. Current ICU Antibiotic Selection (for antibiotic regimen on [date]): A. What is the suspected source of infection? Check all that apply: Head/ Neck Respiratory Abdominal/ GI Neuro/ CNS Cardiac Urinary Reproductive Catheter Associated bloodstream infection Bacteremia, non-catheter related Neutropenic fever Skin and soft tissue Septic joint Sepsis, known focus Sepsis, unknown focus Other, please specify Prophylaxis Unable to tell B. Indicate the antibiotic regimen given on [date]? Drug 1 Drug 2 Drug 3 Drug 4 3. Microbiology: A. Were the following cultures collected before or within 24 hours of the initiation of the antibiotics? a. Blood Y N b. Urine Y N c. Sputum Y N d. CSF Y N e. Pleural fluid Y N f. Pericardial fluid Y N g. Peritoneal fluid Y N h. Synovial Fluid Y N i. Wound Y N j. Other Y N

B. Was an organism isolated by the culture indicated in 3A? a. If yes, which organism and body site? 4. Current Antibiotic Management (Antibiotic Regimen on [date]): A. Is the antibiotic regimen a. Empiric (i.e, antibiotics chosen as an educated guess to cover an infectious syndrome or presentation; if any drugs in antibiotic regimen are empiric, then choose empiric) b. Directed (i.e, antibiotics based on an identified culture or other microbiological result) c. Prophylactic (i.e, antibiotics given to prevent infection) B. How long has this antibiotic regimen been in place? (In this question please consider the drug selection and not the dosing; timing should be based on the longest drug, if a multidrug regimen prescribed) a. 0-24 hours b. 25-72 hours c. >72 hours C. Within the 72 hours prior to [date], was there a positive culture pertinent to syndrome in question? Y N N /A (check one) D. If yes to 4C, were antibiotics modified based on results? Stopped De-escalated IV to PO Switch Continued Escalated N /A Please indicate rationale for treatment decision: E. Was a member of the ASP consulted for assistance with antibiotic management? Y N N /A (check one) F. Was a formal ID consult obtained for subsequent antibiotic management? Y N.. N /A (check one) G. Is the total duration of empiric, prophylactic or directed antibiotic therapy (inpatient and/or outpatient) indicated in the chart? Y N Insufficient information to determine (check one) a. If yes, what is the duration? ASSESSMENT OF PRESCRIBING APPROPRIATENESS (frontline team member working with ASP, pharmacy or ID consultant) 5. In the opinion of the reviewers, were antibiotics appropriate (regimen in question 2B) on [date]? Y N (check one)

6. If inappropriate, please indicate your reason (s) below (check all that apply and then choose the one that is the most salient of the reasons for inappropriateness in your opinion): a) No antibiotics indicated: Non-infectious syndrome Non-bacterial syndrome Treatment of colonization or contamination b) Adjustment in regimen not made in a timely manner c) Antibiotics indicated but, wrong regimen: Coverage: Regimen does not cover all pathogens required (under coverage) Spectrum of activity too broad (over coverage) Redundant antimicrobial coverage (over coverage) Duration: Duration longer than necessary for treatment regimen Duration longer than necessary for empiric regimen Duration longer than necessary for prophylactic regimen Duration shorter than necessary d) Dosing, route or interval inappropriate for infection or renal function Dosing not correct for infection or renal function Route not correct (such as IV rather than PO conversion) Interval not correct for infection or renal function 7. From the reasons identified in 6 above, please check the single most important reason: a) No antibiotics indicated: Non-infectious syndrome Non-bacterial syndrome Treatment of colonization or contamination b) Adjustment in regimen not made in a timely manner c) Antibiotics indicated but, wrong regimen: Coverage: Regimen does not cover all pathogens required (under coverage) Spectrum of activity too broad (over coverage) Redundant antimicrobial coverage (over coverage)

Duration: Duration longer than necessary for treatment regimen Duration longer than necessary for empiric regimen Duration longer than necessary for prophylactic regimen Duration shorter than necessary d) Dosing, route or interval inappropriate for infection or renal function Dosing not correct for infection or renal function Route not correct (such as IV rather than PO conversion) Interval not correct for infection or renal function 8. Please indicate the number of people involved with collecting data for this patient assessment: 9. Please indicate the total amount of time this assessment took (for all of the participating healthcare providers): Appendix: Patients are considered inappropriate for IV to PO conversion if any of the following are present: A. Mucositis B. Malabsorption syndrome or gastrointestinal motility disorder C. Severe nausea, vomiting or diarrhea D. Continuous nasogastric suctioning E. Continuous enteral feeds are contraindicated with oral ciprofloxacin, levofloxacin or moxifloxacin F. Gastrointestinal obstruction H. Need for complete bowel rest I. Patient receiving vasopressors (e.g., Dopamine, Epinephrine, Norepinephrine, Phenylephrine, Vasopressin) References: 1. This form is adapted from CDC Assessment of Appropriateness of Inpatient Antibiotics available at: www.cdc.gov/getsmart/healthcare/pdfs/gen-assessment.docx 2. Hecker MT, Aron DC, Patel NP, et al. Unnecessary use of antimicrobials in hospitalized patients. Arch Intern Med. 2003. 163:972-978 3. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801-810 4. Bhar S, Nori P, Ostrowsky B. Improving Antimicrobial Use Starts with Our Trainees. IDWeek 2015 Abstract 625